Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00844649 · ClinicalTrials.gov registry record · Phase 3
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
A Phase 3 study, sponsored by Celgene.
- Completed
- Registry status
- Phase 3
- Development phase
- 861
- Enrollment target
NCT00844649 is a Phase 3 study that has completed, run by Celgene. The registered enrollment target is 861 participants.
The verdict
NCT00844649, a Phase 3 study, has completed, sponsored by Celgene.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 861 participants
- Enrollment target
Study Summary
Phase III Metastatic Pancreatic Cancer
Interventions
- DRUG Gemcitabine
- DRUG Albumin-bound paclitaxel (ABI-007)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 861 participants |
| Start Date | 2009-03-01 |
| Est. Completion | 2013-04-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00844649
The ClinicalTrials.gov registry entry for NCT00844649 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 861 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Celgene, which has 308 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Gemcitabine is the first listed.
NCT00844649 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00844649 about?
NCT00844649 is a clinical study titled "Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas". Phase III Metastatic Pancreatic Cancer
What is the current status of trial NCT00844649?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 861 participants. The study started on 2009-03-01. Estimated completion is 2013-04-09.
What interventions are being tested in trial NCT00844649?
The interventions under investigation include: Gemcitabine (DRUG), Albumin-bound paclitaxel (ABI-007) (DRUG).
Who is sponsoring clinical trial NCT00844649?
This trial is sponsored by Celgene, which has 308 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.